Drug Type Small molecule drug |
Synonyms USP30 inhibitors (FORMA Therapeutics) |
Target |
Mechanism USP30 inhibitors(ubiquitin specific peptidase 30 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | US | 03 Mar 2020 |